FindTrial
Sign In

A study of peginterferon alfa-2a in combination with ribavirin in patients with chronic Hepatitis C.

A study of peginterferon alfa-2a in combination with ribavirin in patients with chronic Hepatitis C.

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220023
Enrollment
Unknown
Registered
2005-09-01
Start date
2005-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis C

Interventions

investigational material(s) Generic name etc : Peginterferon alpha-2a|ribavirin INN of investigational material : Therapeutic category code : 639 Other biological preparations Dosage and Administrati

Sponsors

Chugai Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Male and female patients and over 20 years of ages with CHC, elevated ALT and detectable HCV RNA.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy and safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026